Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Operating Expenses Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Operating Expenses
-$262.2m
CAGR 3-Years
-10%
CAGR 5-Years
-17%
CAGR 10-Years
-36%
ProQR Therapeutics NV
NASDAQ:PRQR
Operating Expenses
-€44m
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Operating Expenses
-$196.8m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-15%
argenx SE
XBRU:ARGX
Operating Expenses
-$2.2B
CAGR 3-Years
-31%
CAGR 5-Years
-57%
CAGR 10-Years
-83%
Merus NV
NASDAQ:MRUS
Operating Expenses
-$266.9m
CAGR 3-Years
-26%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Operating Expenses
-$46.5m
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Operating Expenses?
Operating Expenses
-262.2m USD

Based on the financial report for Jun 30, 2024, Pharming Group NV's Operating Expenses amounts to -262.2m USD.

What is Pharming Group NV's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-36%

Over the last year, the Operating Expenses growth was -19%. The average annual Operating Expenses growth rates for Pharming Group NV have been -10% over the past three years , -17% over the past five years , and -36% over the past ten years .

Back to Top